S1E2 - EoE: Why I-SEE Matters and Evidence To-Date
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
S1E2 - EoE: Why I-SEE Matters and Evidence To-Date
-
ナレーター：
-
著者：
概要
Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Dr. Evan Dellon and Dr. Emily McGowan discuss the features measured by the I-SEE clinical index and its role in evaluating EoE severity, as well as evidence behind the ongoing validation of this tool and implications for future use.
Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.